[Remote] MRD Clinical Account Executive, Garden State at Tempus

Pennsylvania, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Biotechnology, Medical Devices, PharmaceuticalsIndustries

Requirements

Candidates must possess a Bachelor's degree in life science, biology, business, or marketing, with an MBA preferred. A proven track record of revenue generation in diagnostics, pharmaceuticals, or biotechnology, and at least 3 years of direct account management experience in molecular diagnostics, preferably with MRD testing, is required. The role demands comfort engaging with executive-level stakeholders, an in-depth understanding of the payer and reimbursement environment in oncology diagnostics, and proficiency in Microsoft Office and Salesforce.com. Strong independent work ethic, communication, project management, prioritization, cross-functional relationship building, and advanced presentation and business acumen skills are essential.

Responsibilities

The MRD Clinical Account Executive is responsible for driving the adoption of Tempus's MRD testing services within their territory, engaging with KOLs and clinicians to establish business opportunities, and developing strategic plans for client acquisition and retention. This includes implementing LSAs, collaborating with internal sales roles, identifying partnership opportunities, and providing market feedback to leadership. A comprehensive business plan for the territory, including budgets and goal setting, must be developed and implemented, while consistently representing Tempus's company culture with integrity.

Skills

Precision Medicine

Healthcare Sales

Business Development

Client Relationship Management

Strategic Planning

Territory Management

Market Analysis

Oncology

Minimal Residual Disease (MRD) Testing

Laboratory Services Agreements (LSAs)

Salesforce

Tempus

AI-driven healthcare data analysis platform

About Tempus

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.

Chicago, IllinoisHeadquarters

2015Year Founded

$894.9MTotal Funding

IPOCompany Stage

AI & Machine Learning, Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Relocation Assistance

Company Equity

Performance Bonus

Risks

Competition from partners like Genialis may lead to conflicts of interest.

Ambry Genetics acquisition could pose financial risks if synergies aren't realized.

Technical challenges may arise in integration with Flatiron's OncoEMR platform.

Differentiation

Tempus uses AI to analyze clinical and molecular data for precision medicine.

Their platform aids in personalized treatment decisions for cancer patients.

Tempus collaborates with biotech firms to enhance drug development using real-world data.

Upsides

Increased AI adoption in healthcare boosts Tempus' partnerships and collaborations.

Acquisition of Ambry Genetics expands Tempus' genetic testing capabilities.

Integration with Flatiron's OncoEMR enhances precision in cancer treatment plans.

Land your dream remote job 3x faster with AI

Try Jobo Free